针对早产婴儿的动脉管的重复药理疗程的有效性

Carlo Dani1, Giovanni Sassudelli2, Carlotta Milocchi2

  • 1Department of Neuroscience, Psychology, Drug Research and Child Health, Careggi University Hospital of Florence, Largo Brambilla 3, 50134 Firenze, Italy; Division of Neonatology, Careggi University Hospital of Florence, Largo Brambilla 3, 50134 Firenze, Italy.

Early human development
|December 1, 2024
PubMed
概括

在早产婴儿中,针对血液动力学上显著的专利动脉管 (hsPDA) 进行重复的布洛芬或青疗程显示出失败率的增加. 进一步的药物疗程可能会增加非常早产婴儿的不良影响.